Insufficient scRNA-seq data for expression of IL1RL2 at single-cell level.
Insufficient scRNA-seq data for expression of IL1RL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 379.77 | 653 / 653 | 91% | 9.39 | 550 / 605 |
kidney | 97% | 190.36 | 86 / 89 | 91% | 5.32 | 818 / 901 |
liver | 96% | 173.24 | 217 / 226 | 59% | 2.70 | 241 / 406 |
prostate | 85% | 140.39 | 209 / 245 | 58% | 1.55 | 290 / 502 |
lung | 57% | 61.97 | 327 / 578 | 86% | 4.57 | 999 / 1155 |
breast | 80% | 131.11 | 368 / 459 | 63% | 2.45 | 700 / 1118 |
adrenal gland | 100% | 183.48 | 257 / 258 | 43% | 1.49 | 98 / 230 |
esophagus | 44% | 244.67 | 636 / 1445 | 97% | 6.81 | 177 / 183 |
stomach | 70% | 88.60 | 252 / 359 | 70% | 2.89 | 201 / 286 |
bladder | 38% | 48.52 | 8 / 21 | 84% | 4.37 | 425 / 504 |
ovary | 36% | 36.38 | 65 / 180 | 85% | 3.56 | 365 / 430 |
intestine | 38% | 45.82 | 370 / 966 | 76% | 3.24 | 400 / 527 |
skin | 100% | 743.47 | 1806 / 1809 | 14% | 0.43 | 64 / 472 |
uterus | 25% | 32.78 | 42 / 170 | 88% | 7.42 | 404 / 459 |
tonsil | 0% | 0 | 0 / 0 | 96% | 6.60 | 43 / 45 |
pancreas | 7% | 5.23 | 23 / 328 | 73% | 2.59 | 130 / 178 |
adipose | 56% | 80.42 | 674 / 1204 | 0% | 0 | 0 / 0 |
brain | 37% | 43.47 | 972 / 2642 | 12% | 0.23 | 85 / 705 |
heart | 28% | 26.23 | 243 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 13% | 13.04 | 177 / 1335 | 0% | 0 | 0 / 0 |
muscle | 9% | 7.76 | 69 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.09 | 2 / 29 |
peripheral blood | 4% | 2.95 | 34 / 929 | 0% | 0 | 0 / 0 |
spleen | 3% | 2.07 | 7 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0070498 | Biological process | interleukin-1-mediated signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0006968 | Biological process | cellular defense response |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0045582 | Biological process | positive regulation of T cell differentiation |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0045087 | Biological process | innate immune response |
GO_0005886 | Cellular component | plasma membrane |
GO_0004908 | Molecular function | interleukin-1 receptor activity |
GO_0004909 | Molecular function | interleukin-1, type I, activating receptor activity |
GO_0003953 | Molecular function | NAD+ nucleosidase activity |
GO_0061809 | Molecular function | NAD+ nucleotidase, cyclic ADP-ribose generating |
Gene name | IL1RL2 |
Protein name | Interleukin 1 receptor like 2 Interleukin-1 receptor-like 2 (EC 3.2.2.6) (IL-36 receptor) (IL-36R) (Interleukin-1 receptor-related protein 2) (IL-1Rrp2) (IL1R-rp2) |
Synonyms | IL1RRP2 |
Description | FUNCTION: Receptor for interleukin-36 (IL36A, IL36B and IL36G). After binding to interleukin-36 associates with the coreceptor IL1RAP to form the interleukin-36 receptor complex which mediates interleukin-36-dependent activation of NF-kappa-B, MAPK and other pathways (By similarity). The IL-36 signaling system is thought to be present in epithelial barriers and to take part in local inflammatory response; it is similar to the IL-1 system. Seems to be involved in skin inflammatory response by induction of the IL-23/IL-17/IL-22 pathway. . |
Accessions | ENST00000421464.1 ENST00000441515.3 [Q9HB29-2] Q9HB29 ENST00000264257.7 [Q9HB29-1] C9K0I8 |